Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
1.160
+0.010 (0.87%)
At close: Aug 8, 2025, 4:00 PM
1.131
-0.029 (-2.53%)
After-hours: Aug 8, 2025, 7:05 PM EDT
Hyperfine Revenue
Hyperfine had revenue of $2.14M in the quarter ending March 31, 2025, a decrease of -35.14%. This brings the company's revenue in the last twelve months to $11.73M, up 0.34% year-over-year. In the year 2024, Hyperfine had annual revenue of $12.89M with 16.84% growth.
Revenue (ttm)
$11.73M
Revenue Growth
+0.34%
P/S Ratio
7.25
Revenue / Employee
$105,694
Employees
111
Market Cap
90.29M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12.89M | 1.86M | 16.84% |
Dec 31, 2023 | 11.03M | 4.22M | 61.90% |
Dec 31, 2022 | 6.81M | 5.32M | 355.48% |
Dec 31, 2021 | 1.50M | 1.20M | 408.84% |
Dec 31, 2020 | 294.00K | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
HYPR News
- 6 days ago - Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System - Business Wire
- 10 days ago - Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments - Business Wire
- 11 days ago - Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025 - Business Wire
- 13 days ago - Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer's Association International Conference - Business Wire
- 17 days ago - Hyperfine Swoop® AI-Powered Portable MRI System Showcased in Clinical Studies Designed to Broaden Access to Dementia Care - Business Wire
- 18 days ago - Hyperfine Begins Commercial Launch of Optive AI™ Software, Bringing Substantially Improved Image Quality to the Installed Base of Swoop® Systems - Business Wire
- 24 days ago - Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software - Business Wire
- 2 months ago - Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI - Business Wire